Koné-Paut, Isabelle <br/><br/>
Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study.  [electronic resource] 

 -  Arthritis research & therapy  2011 
 - R202 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1478-6362 
<br/><br/><label>Standard No.: </label>10.1186/ar3535  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>C-Reactive Protein--metabolism<br/>Child<br/>Child, Preschool<br/>Cryopyrin-Associated Periodic Syndromes--blood<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Health Status<br/>Humans<br/>Interleukin-1beta--antagonists & inhibitors<br/>Interleukin-6--blood<br/>Male<br/>Middle Aged<br/>Quality of Life<br/>Remission Induction<br/>Serum Amyloid A Protein--metabolism<br/>Surveys and Questionnaires<br/>Treatment Outcome<br/>Young Adult